DiaMedica Therapeutics (DMAC) Shares Outstanding (2017 - 2026)

DiaMedica Therapeutics (DMAC) has reported Shares Outstanding (Entity) for 10 consecutive years, with $53.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 25.2% year-over-year to $53.9 million; the trailing twelve-month figure through Jun 2026 stood at $53.9 million (up 25.2% YoY), and the FY2025 full-year result was $53.7 million, up 25.51% from the prior year.
• Shares Outstanding (Entity) was little changed at $53.9 million in Q2 2026 per DMAC's latest filing, from $53.9 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $53.9 million in Q2 2026 and bottomed at $26.4 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $39.0 million across 5 years, with a median of $40.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) grew 0.08% in 2023, then soared 56.31% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $26.4 million in 2022, then surged by 43.55% to $38.0 million in 2023, then advanced by 12.81% to $42.8 million in 2024, then gained by 25.51% to $53.7 million in 2025, then grew by 0.34% to $53.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $53.9 million, $53.9 million, and $53.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.